Rana McKay/providers.ucsd.edu
Feb 7, 2025, 21:16
Rana McKay: Frontline mRCC Treatment in 2025
Rana McKay, Associate Professor of Medicine at University of California San Diego, shared a post on X:
“Treatment decisions for frontline RCC getting more complicated with long term data from key landmark studies. We need better (negative selection) biomarkers to choose between IO-IO and IO-VEGF.”
Full Article on ASCO Daily News.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 8, 2025, 14:10
Feb 8, 2025, 14:07
Feb 8, 2025, 13:55
Feb 8, 2025, 13:24